Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2020 | 2 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6.
Eur Addict Res. 2018.
PMID: 29510390
Free PMC article.
Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder.
Coetzee C, Schellekens AFA, Truter I, Meyer A.
Coetzee C, et al.
Eur Addict Res. 2023;29(1):9-18. doi: 10.1159/000526386. Epub 2022 Nov 4.
Eur Addict Res. 2023.
PMID: 36349763
Item in Clipboard
Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder.
Coetzee C, Truter I, Meyer A.
Coetzee C, et al.
S Afr J Psychiatr. 2022 Apr 14;28:1786. doi: 10.4102/sajpsychiatry.v28i0.1786. eCollection 2022.
S Afr J Psychiatr. 2022.
PMID: 35547103
Free PMC article.
Item in Clipboard
Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder.
Coetzee C, Truter I, Meyer A.
Coetzee C, et al.
Expert Rev Clin Pharmacol. 2020 Nov;13(11):1271-1280. doi: 10.1080/17512433.2020.1835467. Epub 2020 Oct 22.
Expert Rev Clin Pharmacol. 2020.
PMID: 33040639
Item in Clipboard
[Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder].
Kapitány-Fövény M, Barta C, Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Coetzee C, Luderer M, Schellekens A, Matthys F, Demetrovics Z; ICASA consensus group.
Kapitány-Fövény M, et al. Among authors: coetzee c.
Psychiatr Hung. 2020;35(4):435-447.
Psychiatr Hung. 2020.
PMID: 33263293
Hungarian.
Item in Clipboard
Cite
Cite